Drug profile · INN
hydrocortisone
HYDROCORTISONE AGUETTANT
- US status
- approved
- Patents linked
- 5
- News articles
- 0
Quick answer
hydrocortisone (HYDROCORTISONE AGUETTANT) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: for rx compounding. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12419831
Hydrocortisone oral liquid formulations
granted -
US 12133914
Hydrocortisone oral liquid formulations
granted -
US 11904046
Hydrocortisone oral liquid formulations
granted -
US 6803359
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
expired -
US 6319900
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
expired
Frequently asked questions
What is hydrocortisone?
hydrocortisone (HYDROCORTISONE AGUETTANT) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: for rx compounding. Current US regulatory status: approved.
What is the brand name for hydrocortisone?
HYDROCORTISONE AGUETTANT is a marketed brand name for hydrocortisone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydrocortisone?
hydrocortisone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.